Patents by Inventor Anna Perez-Bosque

Anna Perez-Bosque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Animal plasma or fractions thereof for use in treating cognitive impairment disorders in humans and companion animals
    Patent number: 11690871
    Abstract: The present application relates to the administration of plasma, fractions thereof, or mixtures thereof to humans or animals to treat or otherwise improve cognitive impairment disorders, including dementia (e.g., vascular dementia, dementia with Lewy bodies, dementia resulting from Alzheimer's disease, dementia resulting from Parkinson's disease, frontotemporal dementia, and dementia resulting from normal pressure hydrocephalus in humans, and cognitive dysfunction syndrome in companion animals), concussion, and traumatic brain injury.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: July 4, 2023
    Assignee: APC EUROPE SLU
    Inventors: Francisco Javier Polo Pozo, Louis Edward Russell, María Carmen Rodríguez Canel, Joy Marlene Campbell, Joe David Crenshaw, Miquel Moretó Pedragosa, Anna Pérez Bosque, Lluïsa Miró Martí
  • ANIMAL PLASMA OR FRACTIONS THEREOF FOR USE IN TREATING COGNITIVE IMPAIRMENT DISORDERS IN HUMANS AND COMPANION ANIMALS
    Publication number: 20210260112
    Abstract: The present application relates to the administration of plasma, fractions thereof, or mixtures thereof to humans or animals to treat or otherwise improve cognitive impairment disorders, including dementia (e.g.
    Type: Application
    Filed: May 17, 2018
    Publication date: August 26, 2021
    Applicant: APC EUROPE SLU
    Inventors: Francisco Javier POLO POZO, Louis Edward RUSSELL, María Carmen RODRÍGUEZ CANEL, Joy Marlene CAMPBELL, Joe David CRENSHAW, Miquel MORETÓ PEDRAGOSA, Anna PÉREZ BOSQUE, Lluïsa MIRÓ MARTÍ
  • Methods and compositions containing at least 30% IgG and 10% or less by weight IgA for reducing lung inflammation in an animal
    Patent number: 9616091
    Abstract: The present invention provides methods for reducing, attenuating, diminishing, preventing or inhibiting pulmonary inflammation in an animal by orally administering a plasma fraction comprising at least 30% by weight IgG and 10% or less by weight IgA to said animal prior to or following exposure or challenge of the animal to an endotoxin.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: April 11, 2017
    Assignee: THE LAURIDSEN GROUP, INC.
    Inventors: Eric Weaver, Joy Campbell, Louis Russell, Miquel Moreto Pedragosa, Anna Perez-Bosque, Francisco Javier Polo Pozo, Joseph Crenshaw
  • Methods and Compositions for Reducing Lung Inflammation in an Animal
    Publication number: 20110135581
    Abstract: The present invention provides methods for reducing, attenuating, diminishing, preventing or inhibiting pulmonary inflammation in an animal by orally administering a plasma fraction to said animal prior to or following exposure or challenge of the animal to an endotoxin.
    Type: Application
    Filed: May 22, 2009
    Publication date: June 9, 2011
    Applicant: THE LAURIDSEN GROUP, INC.
    Inventors: Eric Weaver, Joy Campbell, Louis Russell, Miquel Moreto Pedragosa, Anna Perez-Bosque, Francisco Javier Polo Pozo, Joseph Crenshaw